These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11304897)

  • 21. Quinupristin/dalfopristin.
    Med Lett Drugs Ther; 1999 Nov; 41(1066):109-10. PubMed ID: 10987009
    [No Abstract]   [Full Text] [Related]  

  • 22. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.
    Griswold MW; Lomaestro BM; Briceland LL
    Am J Health Syst Pharm; 1996 Sep; 53(17):2045-53. PubMed ID: 8870891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arthralgias and myalgias related to quinupristin-dalfopristin administration.
    Olsen KM; Rebuck JA; Rupp ME
    Clin Infect Dis; 2001 Feb; 32(4):e83-6. PubMed ID: 11181142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.
    Drew RH; Perfect JR; Srinath L; Kurkimilis E; Dowzicky M; Talbot GH
    J Antimicrob Chemother; 2000 Nov; 46(5):775-84. PubMed ID: 11062197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers.
    Lasseter K; Dilzer S; Jansat JM; Garcia Gil E; Caracta CF; Ortiz S
    Pulm Pharmacol Ther; 2012 Apr; 25(2):193-9. PubMed ID: 22366196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of quinupristin-dalfopristin (Synercid) and their main metabolites during continuous veno-venous hemofiltration (CVVH) with or without dialysis.
    Kim MK; Banevicius MA; Zhong M; Shi X; Hu M; Nightingale CH; Nicolau DP
    Int J Artif Organs; 2002 Jan; 25(1):33-9. PubMed ID: 11853069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation.
    Hussein Z; Mukherjee D; Lamm J; Cavanaugh JH; Granneman GR
    J Clin Pharmacol; 1994 Jul; 34(7):754-9. PubMed ID: 7929870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with quinupristin/dalfopristin in treating infections with vancomycin-resistant Enterococcus faecium in children.
    Gray JW; Darbyshire PJ; Beath SV; Kelly D; Mann JR
    Pediatr Infect Dis J; 2000 Mar; 19(3):234-8. PubMed ID: 10749466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects.
    Saisho Y; Katsube T; White S; Fukase H; Shimada J
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
    Stass H; Kubitza D; Schühly U
    Clin Pharmacokinet; 2001; 40 Suppl 1():1-9. PubMed ID: 11352436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers.
    Da Ros L; Squassante L; Milleri S
    Clin Pharmacokinet; 2003; 42(1):99-106. PubMed ID: 12489980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
    Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
    Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.